ReportGem ReportGem 中文

REAL-TIME GLOBAL RESEARCH

SUGI HOLDINGS (7649): 1Q FY2/27 results: Core business somewhat weak; positive long-term impression of issuing new shares to GIC’s strategic investment unit

Published: 2026-07-09Institution: JPMorganPages: 8Original language: EnglishEvidence page: 1

Research evidence excerpt

SUGI HOLDINGS (7649): 1Q FY2/27 results: Core business somewhat weak; positive long-term impression of issuing new shares to GIC’s strategic investment unit

J P M O R G A N Asia Pacific Equity Research

10 July 2026

SUGI HOLDINGS (7649)

1Q FY2/27 results: Core business somewhat weak; Overweight

positive long-term impression of issuing new shares to 7649.T, 7649 JP

GIC’s strategic investment unit Price (09 Jul 26):¥3,178

Price Target (Dec-26):¥3,800

Somewhat negative: 1Q operating profit grew 10.9% to ¥12.2 billion, in line with Japan Equity Research

our estimate of ¥12.1 billion and the Bloomberg consensus estimate of ¥11.9

Retail

billion. The shortfall in product sales gross profit is a concern. However, Sugi

Holdings announced a capital increase via private placement of new shares to GIC. Dairo Murata AC

The issue price is ¥3,195 per share (a 10% discount from the July 8 closing price), (81-3) 6736 8620

dairo.murata@jpmorgan.com

the total issuance amount is around ¥16 billion, and the number of issued shares is

Ami Terai

16,237 million. Sugi’s KPI targets in the medium-term plan announced in April (81-3) 6736-8660

are unchanged. ami.terai@jpmorgan.com

• 1Q results: Consolidated sales grew 10.1%, the gross margin was 30.8%, costs Kazuha(81-3) 6736-8614Matsuo

rose 10.1%, and operating profit was ¥12.2 billion. We forecast sales growth kazuha.matsuo@jpmorgan.com

of 8.7%, gross margin of 31.2%, and cost growth of 10.2%. Sales growth and JPMorgan Securities Japan Co., Ltd.

operating profit were above our estimates, the gross margin was below, and

costs were in line. A gross profit breakdown shows the dispensing business

remained strong, due mainly to the acquisition of high-priced dispensing. The

product sales business missed guidance, due mainly to consumers becoming

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer